For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs—commonly referred to as antiretroviral therapy—the virus usually rushes ...
Thousands of low-income Americans with HIV are losing access to vital medications, as states grapple with a lack of federal ...
Dr. Paula Cannon is pursuing one of medicine’s most difficult goals: a cure for HIV.
After launching a PrEP medication that was 100% effective in clinical trials, the company is facing a complex global rollout and leveraging its network of partners for help.
With NIH funding, the group will pursue research and patient care approaches for a disease that affects more than 250 million people around the globe ...
US-supported international HIV research, particularly that conducted in African countries, has direct benefits to Americans. Cuts to that research may undermine those benefits.
Add Yahoo as a preferred source to see more of our stories on Google. A new single-pill HIV treatment has proved as effective as regimens of up to 11 tablets a day in suppressing the virus in ...
A new single-pill HIV treatment has proved as effective as regimens of up to 11 tablets a day in suppressing the virus in hard-to-treat patients. It’s “a potential breakthrough for a growing cohort of ...
HIV activist Rathabeng Mamabolo highlights the alarming trend of men relying on partners for HIV testing, urging a shift towards personal responsibility in health management.
The Western North Carolina AIDS Project's annual Dining Out for Life event is fast approaching.